CEP63 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.468000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.485400E-01
Normal-vs-Stage2
3.815800E-01
Normal-vs-Stage3
1.672390E-01
Normal-vs-Stage4
4.202400E-01
Stage1-vs-Stage2
2.546600E-01
Stage1-vs-Stage3
9.314300E-02
Stage1-vs-Stage4
2.701600E-01
Stage2-vs-Stage3
2.384000E-01
Stage2-vs-Stage4
1.759510E-02
Stage3-vs-Stage4
6.016300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.407800E-01
Normal-vs-AfricanAmerican
1.636030E-01
Normal-vs-Asian
4.027400E-01
Caucasian-vs-AfricanAmerican
4.485400E-01
Caucasian-vs-Asian
5.007000E-01
AfricanAmerican-vs-Asian
8.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.472000E-01
Normal-vs-Female
4.623400E-01
Male-vs-Female
9.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.192600E-01
Normal-vs-Age(41-60Yrs)
7.607400E-01
Normal-vs-Age(61-80Yrs)
3.201800E-01
Normal-vs-Age(81-100Yrs)
4.071600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.606000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.869600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.882600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.444300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.628600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.671200E-01
Normal-vs-Daily Drinker
4.962100E-02
Normal-vs-Weekly Drinker
1.760380E-01
Normal-vs-Occasional Drinker
8.870600E-01
Normal-vs-Social Drinker
7.387600E-01
Non Drinker-vs-Daily Drinker
3.975600E-01
Non Drinker-vs-Weekly Drinker
6.020000E-01
Non Drinker-vs-Occasional Drinker
2.033700E-02
Non Drinker-vs-Social Drinker
1.333980E-01
Daily Drinker-vs-Weekly Drinker
8.751200E-01
Daily Drinker-vs-Occasional Drinker
4.444700E-03
Daily Drinker-vs-Social Drinker
1.464420E-02
Weekly Drinker-vs-Occasional Drinker
2.204400E-02
Weekly Drinker-vs-Social Drinker
7.882300E-02
Occasional Drinker-vs-Social Drinker
4.360400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.320400E-02
Normal-vs-Grade 2
4.621900E-03
Normal-vs-Grade 3
5.421700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.747400E-01
Grade 1-vs-Grade 3
1.387820E-01
Grade 1-vs-Grade 4
5.320400E-02
Grade 2-vs-Grade 3
1.495180E-01
Grade 2-vs-Grade 4
4.621900E-03
Grade 3-vs-Grade 4
5.421700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.848030E-01
Normal-vs-NonDiabetic
3.686400E-01
Diabetic-vs-NonDiabetic
5.216200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.278000E-01
Normal-vs-NoPancreatitis
3.513000E-01
Pancreatitis-vs-NoPancreatitis
7.180800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.336400E-01
Normal-vs-N1
4.095800E-01
N0-vs-N1
6.435000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.437600E-01
Normal-vs-TP53-NonMutant
7.175600E-01
TP53-Mutant-vs-TP53-NonMutant
5.696400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
